Brian Edwin Cathers insider trades: Global Blood Therapeutics (GBT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2020 | GBT | ↓ Sell | 2,200 | $63.77 | $140K | Direct | Aug 24, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Brian Edwin Cathers's insider trades
Brian Edwin Cathers is Chief Scientific Officer at Global Blood Therapeutics (GBT). Since Aug 20, 2020, Brian has reported no open-market purchases and 1 sale worth $140K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), shares withheld for taxes (5 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GBT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.